This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2007.08.031v1 50/23/2226    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Hink, U. Articles by Munzel, T. Search for Related Content PubMed PubMed Citation Articles by Hink, U. Articles by Munzel, T. Related Collections Related Article

CLINICAL RESEARCH: CARDIAC PHARMACOLOGY

Oxidative Inhibition of the Mitochondrial Aldehyde Dehydrogenase Promotes Nitroglycerin Tolerance in Human Blood Vessels

Ulrich Hink, MD^_*, Andreas Daiber, PhD^_*, Nalan Kayhan, MD, Jordis Trischler, MS^_*, Catharina Kraatz, MS^_*, Matthias Oelze, PhD^_*, Hanke Mollnau, MD^_*, Philip Wenzel, MD^_*, Christian F. Vahl, MD, Kwok Ki Ho, PhD, Henry Weiner, PhD and Thomas Munzel, MD^_*,_*

^_* II Medizinische Klinik für Kardiologie und Angiologie, Johannes Gutenberg University, Mainz, Germany
Klinik für Herz, Thorax und Gefäßchirurgie, Johannes Gutenberg University, Mainz, Germany
Purdue University, West Lafayette, Indiana.

Manuscript received October 13, 2006; revised manuscript received July 10, 2007, accepted August 16, 2007.

^_* Reprint requests and correspondence: Dr. Thomas Münzel, II Medizinische Klinik und Poliklinik, Johannes Gutenberg Universität Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany. (Email: tmuenzel{at}uni-mainz.de).

Objectives: We tested the hypothesis of whether an inhibition of the nitroglycerin (GTN) bioactivating enzyme mitochondrial aldehyde dehydrogenase (ALDH-2) contributes to GTN tolerance in human blood vessels.

Background: The hemodynamic effects of GTN are rapidly blunted by the development of tolerance, a phenomenon associated with increased formation of reactive oxygen species (ROS). Recent studies suggest that ROS-induced inhibition of ALDH-2 accounts for tolerance in animal models.

Methods: Segments of surgically removed arteria mammaria and vena saphena from patients undergoing coronary bypass surgery were used to examine the vascular responsiveness to GTN and the endothelium-dependent vasodilator acetylcholine. The ALDH-2 activity and expression in these segments were assessed by the conversion of a benzaldehyde or its derivative to the benzoic acid metabolite and by Western blotting technique.

Results: In contrast to patients not treated with nitrates (n = 36), patients treated with GTN for 48 h (n = 14) before surgery showed tolerance to GTN and endothelial dysfunction in arterial and venous vessels. In vivo GTN tolerance was mimicked in vitro by incubation of nontolerant vessels with the ALDH-2 inhibitor benomyl. In vivo GTN treatment decreased vascular aldehyde dehydrogenase activity compared with nontolerant vessels and decreased the expression of ALDH-2 in arterial tissue. Incubation of control venous vessels with GTN caused a significant attenuation of aldehyde dehydrogenase activity that was reversed by presence of the sulfhydryl group donor dithiothreitol.

Conclusions: Long-term GTN treatment induces tolerance and endothelial dysfunction in human vessels, associated with an inhibition and down-regulation of vascular ALDH-2. Thus, these findings extend results of previous animal studies to humans.

Abbreviations and Acronyms   ALDH-2 = mitochondrial aldehyde dehydrogenase   DTT = dithiothreitol   EC50 = half-maximal concentration   eNOS = endothelial nitric oxide synthase   GTN = glycerol trinitrate, nitroglycerin   ROS = reactive oxygen species

Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2007 50: A31-A32. [Full Text] [PDF]

This article has been cited by other articles:

				P. J. Fadel, M. Farias III, K. M. Gallagher, Z. Wang, and G. D. Thomas Oxidative stress and enhanced sympathetic vasoconstriction in contracting muscles of nitrate-tolerant rats and humans J. Physiol., January 15, 2012; 590(2): 395 - 407. [Abstract] [Full Text] [PDF]

				S. Sakata, T. Yoshihara, H. Arima, F. Shiraishi, H. Oniki, F. Takahashi-Yanaga, K. Matsumura, and T. Sasaguri Differential effects of organic nitrates on arterial diameter among healthy Japanese participants with different mitochondrial aldehyde dehydrogenase 2 genotypes: randomised crossover trial BMJ Open, September 2, 2011; 1(1): e000133 - e000133. [Abstract] [Full Text] [PDF]

				T. Munzel, A. Daiber, and T. Gori Nitrate Therapy: New Aspects Concerning Molecular Action and Tolerance Circulation, May 17, 2011; 123(19): 2132 - 2144. [Full Text] [PDF]

				M. Griesberger, A. Kollau, G. Wolkart, M. V. Wenzl, M. Beretta, M. Russwurm, D. Koesling, K. Schmidt, A. C. F. Gorren, and B. Mayer Bioactivation of Pentaerythrityl Tetranitrate by Mitochondrial Aldehyde Dehydrogenase Mol. Pharmacol., March 1, 2011; 79(3): 541 - 548. [Abstract] [Full Text] [PDF]

				C.-H. Chen, L. Sun, and D. Mochly-Rosen Mitochondrial aldehyde dehydrogenase and cardiac diseases Cardiovasc Res, October 1, 2010; 88(1): 51 - 57. [Abstract] [Full Text] [PDF]

				R. Guo, X.-P. Chen, X. Guo, L. Chen, D. Li, J. Peng, and Y.-J. Li Evidence for Involvement of Calcitonin Gene-Related Peptide in Nitroglycerin Response and Association With Mitochondrial Aldehyde Dehydrogenase-2 (ALDH2) Glu504Lys Polymorphism J. Am. Coll. Cardiol., September 9, 2008; 52(11): 953 - 960. [Abstract] [Full Text] [PDF]

				U. Hink, M.-S. S. Alhamdani, and T. Munzel Nitroglycerin Hits the Nerve: Role for Mitochondrial Aldehyde Dehydrogenase? J. Am. Coll. Cardiol., September 9, 2008; 52(11): 961 - 963. [Full Text] [PDF]